Cardax is a consumer health company marketing ZanthoSyn, a physician-recommended astaxanthin dietary supplement for inflammatory health. Its technical focus spans pharmaceutical development, anti-inflammatory compounds, and chronic disease treatment. The company holds 28 issued patents in these areas.
Operating within the consumer health, pharmaceuticals, and dietary supplements sectors, Cardax maintains a reduced corporate cost structure to improve operating cash flow and work toward profitability. The management team brings over twenty years of biotechnology industry experience.
